Mesirow Financial Investment Management Inc. Trims Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mesirow Financial Investment Management Inc. lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 36.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,925 shares of the company’s stock after selling 1,708 shares during the period. Mesirow Financial Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $228,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. raised its holdings in GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after buying an additional 4,107,746 shares during the period. Norges Bank purchased a new stake in GE HealthCare Technologies in the 4th quarter valued at about $229,052,000. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 5.2% in the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after buying an additional 2,647,204 shares during the period. Perpetual Ltd purchased a new stake in GE HealthCare Technologies in the 1st quarter valued at about $96,135,000. Finally, Jacobs Levy Equity Management Inc. raised its holdings in GE HealthCare Technologies by 4,959.8% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after buying an additional 743,523 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $86.79 on Wednesday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company has a market cap of $39.62 billion, a PE ratio of 25.38, a P/E/G ratio of 3.26 and a beta of 1.17. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The business has a 50-day simple moving average of $83.26 and a 200-day simple moving average of $83.31.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the previous year, the company posted $0.92 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on GEHC. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective on the stock. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Six analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $94.58.

Insider Activity at GE HealthCare Technologies

In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.